Bulevirtide vs Exenatide

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Bulevirtide is primarily a antiviral peptide, while Exenatide is used for weight management & metabolic.

This page compares Bulevirtide and Exenatide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

BulevirtideExenatide
CategoryAntiviralWeight Management & Metabolic
Regulatory status (US)FDA approvedFDA approved
Typical dosage5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise)
FrequencyTwice daily (Byetta) or once weekly (Bydureon)
Reported benefitsGlycemic control (HbA1c reduction 0.8–1.9 percentage points), modest body weight reduction (2–4 kg), low intrinsic hypoglycemia risk, modest systolic blood pressure reduction, cardiovascular non-inferiority established in EXSCEL
Reported side effectsNausea, vomiting, diarrhea, injection site reactions, hypoglycemia (when co-administered with sulfonylureas), rare acute pancreatitis, rare acute kidney injury

Key differences

Primary use. Bulevirtide is categorised under Antiviral, while Exenatide falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Bulevirtide: FDA-approved. Exenatide: FDA-approved.

Dosing. Typical dosing for Bulevirtide is not catalogued. Exenatide is typically dosed at 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) (Twice daily (Byetta) or once weekly (Bydureon)).

Can you stack them?

Some protocols combine peptides, but stacking Bulevirtide and Exenatide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Bulevirtide and Exenatide?
Bulevirtide is primarily a antiviral peptide, while Exenatide is used for weight management & metabolic. Bulevirtide is FDA-approved for one or more indications, whereas Exenatide is FDA-approved for one or more indications.
What is Bulevirtide used for?
First/only FDA-approved treatment for chronic hepatitis delta virus (HDV). FDA accelerated approval May 22, 2026. Brand: Hepcludex (Gilead).
What is Exenatide used for?
FDA-approved GLP-1 receptor agonist for type 2 diabetes; the first incretin mimetic approved in the US.
Can you take Bulevirtide and Exenatide together?
Some users combine peptides within a single protocol, but stacking Bulevirtide and Exenatide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Bulevirtide or Exenatide FDA-approved?
Bulevirtide is FDA-approved for one or more indications. Exenatide is FDA-approved for one or more indications.

Read the full articles

  • Bulevirtide — full monograph: mechanism, research, dosing & references
  • Exenatide — full monograph: mechanism, research, dosing & references

Bulevirtide compared across categories

← All peptide comparisons